• 
• 
• 

FDA News and Drug Updates

FDA Approves Polivy in Combination with Bendamustine plus rituximab for Patients with Relapsed, Refractory DLBCL

Xpovio plus Dexamethasone Combination Receives Accelerated Approval for the Treatment of Patients with Relapsed or Refractory MM

FDA News

Supportive Care

What an Aging Population Means for Cancer Treatment

Saima Iqbal, Ishmam Khan

Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting

Meg Barbor, MPH

A Taxing Consequence: Taxane Acute Pain Syndrome

Mark L. Zangardi, PharmD, BCOP

View All Supportive Care Articles

Lung Cancer

Repotrectinib, an Investigational TKI, Induces Response in ROS1-Fusion–Positive NSCLC

Wayne Kuznar

Osimertinib plus Savolitinib Promising for Non–Small-Cell Lung Cancer with MET-Driven Resistance

Phoebe Starr

High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Non–Small-Cell Lung Cancer

Phoebe Starr

View All Lung Cancer Articles

Conference Correspondent

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

The Importance of Compassion: Perspective From a Lifelong Patient

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer

Addressing the Second Victim Phenomenon

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

View All Conference Correspondent Articles

Most Popular Articles

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

TOP - August 2019, Vol 12, No 3 - Immunotherapy

FDA News

TOP - August 2019, Vol 12, No 3 - FDA Approvals

FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs

Phoebe Starr

TOP - August 2019, Vol 12, No 3 - ASCO

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

Yvette Florio Lane

Web Exclusives - FDA Approvals, In the News